Histoplasmosis Treatment Market Size

Histoplasmosis Treatment Market size is expected to reach USD 62 Billion by the end of 2036, growing at a CAGR of 9% during the forecast period i.e., 2024-2036. In the year 2023, the industry size of histoplasmosis treatment was over USD 2 billion. The growth of the market can be attributed to the increasing incidences of histoplasmosis, especially amongst a few specific occupational groups. It is very common in construction workers, poultry farmers, and people with weakened immune systems. A study calculated the incidence of histoplasmosis in U.S. adults 65 years old and older at 3.4 cases for every 100,000 population.

Histoplasmosis is a relatively uncommon disease, so it can be tough to diagnose. However, as awareness of the disease increases, healthcare professionals are more likely to consider it as a potential diagnosis that can lead to earlier and more effective treatment. Therefore, growing awareness about histoplasmosis treatment among healthcare professionals as well as the population is expected to boost the market growth in the projected period.